Format

Send to

Choose Destination
Steroids. 2014 Sep;87:59-66. doi: 10.1016/j.steroids.2014.05.024. Epub 2014 Jun 10.

Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle.

Author information

1
Geriatric Research, Education and Clinical Center, VA Medical Center, Gainesville, FL, United States; Applied Physiology & Kinesiology, University of Florida, Gainesville, FL, United States. Electronic address: evan1979@ufl.edu.
2
Rural Health, VA Medical Center, Gainesville, FL, United States; Animal Sciences, University of Florida, Gainesville, FL, United States.
3
Physical Therapy, University of Florida, Gainesville, FL, United States.
4
Geriatric Research, Education and Clinical Center, VA Medical Center, Gainesville, FL, United States.
5
Applied Physiology & Kinesiology, University of Florida, Gainesville, FL, United States; Research, VA Medical Center, Gainesville, FL, United States.
6
Geriatric Research, Education and Clinical Center, VA Medical Center, Gainesville, FL, United States; Applied Physiology & Kinesiology, University of Florida, Gainesville, FL, United States.

Abstract

Androgens regulate body composition and skeletal muscle mass in males, but the molecular mechanisms are not fully understood. Recently, we demonstrated that trenbolone (a potent synthetic testosterone analogue that is not a substrate for 5-alpha reductase or for aromatase) induces myotrophic effects in skeletal muscle without causing prostate enlargement, which is in contrast to the known prostate enlarging effects of testosterone. These previous results suggest that the 5α-reduction of testosterone is not required for myotrophic action. We now report differential gene expression in response to testosterone versus trenbolone in the highly androgen-sensitive levator ani/bulbocavernosus (LABC) muscle complex of the adult rat after 6weeks of orchiectomy (ORX), using real time PCR. The ORX-induced expression of atrogenes (Muscle RING-finger protein-1 [MuRF1] and atrogin-1) was suppressed by both androgens, with trenbolone producing a greater suppression of atrogin-1 mRNA compared to testosterone. Both androgens elevated expression of anabolic genes (insulin-like growth factor-1 and mechano-growth factor) after ORX. ORX-induced increases in expression of glucocorticoid receptor (GR) mRNA were suppressed by trenbolone treatment, but not testosterone. In ORX animals, testosterone promoted WNT1-inducible-signaling pathway protein 2 (WISP-2) gene expression while trenbolone did not. Testosterone and trenbolone equally enhanced muscle regeneration as shown by increases in LABC mass and in protein expression of embryonic myosin by western blotting. In addition, testosterone increased WISP-2 protein levels. Together, these findings identify specific mechanisms by which testosterone and trenbolone may regulate skeletal muscle maintenance and growth.

KEYWORDS:

Androgen; Atrophy; Hypertrophy; Hypogonadism; Skeletal muscle

PMID:
24928725
DOI:
10.1016/j.steroids.2014.05.024
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center